[Company Logo Image] 

 

Home
HIV Testing
Protocol Screening
Clinical Trials
Social Services
Fund Raising
Contact Us!

 

Complications of HIV

 

 


 

Protocol Title
A5030 A Phase III, Prospective, Randomized, Double-Blind Trial of Valganciclovir Pre-Emptive Therapy for Cytomegalovirus (CMV) Viremia as Detected by Plasma CMV DNA PCR Assay
A5148 A Pilot Study of the Safety, Efficacy, and Tolerability of Extended-Release Niacin (Niaspan) for the Treatment of Elevated Non-HDL-Cholesterol and Elevated Triglycerides in HIV-Infected Subjects
AI424-067-014 A Phase IIIB, Open-label Randomized, Multicenter Study Evaluating the Effect on Serum Lipids Following a Switch to the Protease Inhibitor (PI) Atazanavir in HIV-1 Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy
PR01-29-024 An Open-Labeled Study to Evaluate the Effect of Every Other Week PROCRIT®  (Epoetin alfa) Dosing on Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients

 

© 1997-2003 University of Miami School of Medicine ACRU
All Rights Reserved.
Last modified: June 2003